Boston Private Bank & Trust’s Novo Nordisk NVO Stock Holding History

Boston Private Bank & Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$22K	Sell	810 -400	-33%	-$9.21K	﹤0.01%	721
2014 Q4	$26K	Sell	1,210 -50	-4%	-$1.12K	﹤0.01%	710
2014 Q3	$30K	Hold	1,260	–	–	﹤0.01%	695
2014 Q2	$29K	Sell	1,260 -400	-24%	-$8.83K	﹤0.01%	675
2014 Q1	$38K	Sell	1,660 -710	-30%	-$15.1K	﹤0.01%	647
2013 Q4	$44K	Buy	2,370 +1,120	+90%	+$19.5K	﹤0.01%	614
2013 Q3	$21K	Hold	1,250	–	–	﹤0.01%	693
2013 Q2	$19K	Buy	+1,250	New	+$20.8K	﹤0.01%	683

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Boston Private Bank & Trust's NVO Position: Q1 2015 in Review

Boston Private Bank & Trust reduced its Novo Nordisk (NVO) stake by 33% in Q1 2015, selling an estimated $9.21K and leaving 810 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #721.

Boston Private Bank & Trust first reported a position in NVO in Q2 2013 and has held it in 8 quarters since. The position peaked at $44K in Q4 2013. 506 funds tracked by Wall St. Rank hold NVO as of Q1 2015.

Boston Private Bank & Trust held 810 shares of Novo Nordisk worth $22K as of Q1 2015.
Boston Private Bank & Trust sold 400 Novo Nordisk shares in Q1 2015, an estimated $9.21K.
Novo Nordisk made up ﹤0.01% of Boston Private Bank & Trust's portfolio in Q1 2015, its #721 holding.
Boston Private Bank & Trust first reported a position in Novo Nordisk in Q2 2013 and has held it in 8 quarters since.
Boston Private Bank & Trust's Novo Nordisk position peaked at $44K in Q4 2013.
506 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2015.

Based on Boston Private Bank & Trust's 13F filing for Q1 2015, filed 9 Apr 2015.